You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Taiho begins latest non-small cell lung cancer trial

The randomised, multi-location, open-label, global trial is currently enrolling adults and aims to analyse progression-free survival in the zipalertinib plus chemotherapy arm versus the chemotherapy arm.